Physician profile
Howard Wang
NPI 1447592282
$7,193.75
in general payments reported to CMS, 2019-2025
12 companies · $1,133 in 2025
The $1,133 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $303 · 2021: $352 · 2022: $3,352 · 2023: $1,406 · 2024: $475 · 2025: $1,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,278 · Travel and Lodging: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,278.08 |
| Travel and Lodging | $736.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $4,046.82 | 2022-2024 | Trumatch |
| Kls-Martin L.P. | $1,827.45 | 2021-2025 | |
| Integra Lifesciences Corporation | $608.73 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $173.52 | 2025 | Delta, Medpor |
| Abbvie INC. | $141.67 | 2025 | |
| Kci USA, INC. | $86.52 | 2020 | |
| Avita Medical Americas, LLC | $76.08 | 2024 | |
| Depuy Synthes Sales INC. | $73.20 | 2023 | Rapidsorb |
| Motiva USA, LLC | $70.78 | 2025 | |
| Mentor Worldwide LLC | $55.50 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Ethicon US, LLC | $33.48 | 2024 | Dermabond Prineo |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.